Biogen Idec Inc. - Search Videos

Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Conference, Nov-10-2025 11

Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Conference, Nov-10-2025 11

Gráfico de Biogen (BIIB) en tiempo real - Investing.com

Gráfico de Biogen (BIIB) en tiempo real - Investing.com

Biogen Idec Inc. has Changed its Name to Biogen

Biogen Idec Inc. has Changed its Name to Biogen

marketscreener.com

Grafico Biogen | analisi IA svela trend in tempo reale

Grafico Biogen | analisi IA svela trend in tempo reale

Biogen Idec beefs up pain pipeline

Biogen Idec beefs up pain pipeline

Company | Biogen

Company | Biogen

Careers | Biogen

Careers | Biogen

CoLab | Community Lab | Biogen

バイオジェン・ジャパンについて | Biogen

Job Search | Biogen Careers

As 2024 wraps up, we’re reflecting on all that we’ve accomplished and how our teams around the world continue to make an impact. From innovating science to supporting their local communities, we’re proud to be Team Biogen. | Biogen

324 viewsDec 30, 2024

We’re committed to helping Multiple Sclerosis (MS) and Spinal Muscular Atrophy (SMA) patients continue to have access to prescribed Biogen medicines. Our US Patient Services team is working diligently to connect patients and caregivers with the appropriate support. | Biogen

23K viewsJul 14, 2020

Hedge Funds Are Dumping Biogen Inc. (BIIB)

insidermonkey.com

Ex-Biogen Idec executive settles insider trading case

Multiple Sclerosis | Biogen

Biogen to invest $2 billion in RTP, open new factory in 2025

Student Programs | Biogen

Our scientists are working to advance technology to combat errors occurring in brain cells that can lead to debilitating neurological diseases like spinal muscular atrophy (SMA). Sign up to receive updates and news of Biogen’s pioneering science: | Biogen

533 viewsJun 2, 2021

Biogen | LinkedIn

Clinical Trials | Biogen

Spinal Muscular Atrophy (SMA) | Biogen

Today represents continued progress in Biogen's commitment to Alzheimer's patients. Click here to get the latest Biogen update and learn more about the U.S. FDA’s approval. | Biogen

6.8K viewsJun 7, 2021

Biogen’s manufacturing began in Cambridge in the 1980s and has since expanded its footprint around the world. Learn more about our manufacturing capabilities from Paul McKenzie, EVP, PO&T #Biogen40 | Biogen

1.7K viewsOct 3, 2018

Biogen Inc.: Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

finanznachrichten.de

We’re evolving and diversifying our pipeline. Learn about our focus in immunology, neurology and rare disease. | Biogen

7.3K views8 months ago

Biogen stock surges on report of potential acquisition by Samsung Group

250.2K viewsDec 29, 2021

YahooYahoo Finance Video

Biogen Inc.: Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome

finanznachrichten.de

Biogen’s manufacturing began in Cambridge in the 1980s and has since expanded its footprint around the world. Today, we are looking to the future of manufacturing at Biogen with our next-generation facility in Solothurn, Switzerland (where we broke ground in 2016). #Biogen40 | Biogen

6.9K viewsOct 10, 2018

We’re building the new Biogen as we enter our next era of growth. Our CEO was joined by state and local officials, our co-founders and other community leaders to break ground at our new global headquarters in Kendall Square – planned to open in 2028. Find out more about the new Biogen: https://ow.ly/ee0H50X19p1 | Biogen

853 views8 months ago

In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer's drug

goodmorningamerica.com

See more